BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (2008) 81, 918-919
© 2008 British Institute of Radiology
doi: 10.1259/bjr/22537486

This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GRAY, L
Right arrow Articles by O'REILLY, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GRAY, L
Right arrow Articles by O'REILLY, G
British Journal of Radiology 81 (2008),918-919 ©2008 The British Institute of Radiology

Correspondence

Paediatric diagnostic reference levels in nuclear medicine imaging in Ireland

The Editor — Sir,

The European Medical Exposures Directive (97/43/EURATOM) states that "member states shall promote the establishment and use of diagnostic reference levels for radiodiagnostic examinations" [1], and this recommendation was transposed in to Irish Legislation in 2002 [2]. To date, there exists a deficit in the published literature on the establishment of paediatric diagnostic reference levels (DRLs) for nuclear medicine examinations. We conducted a review of paediatric nuclear medicine services within Ireland, with a view to establishing paediatric DRLs for common nuclear medicine examinations.

In nuclear medicine imaging, DRLs are levels of activity, for typical examinations, for groups of standard sized patients [1, 2]. However, paediatric nuclear medicine imaging does not deal with standard sized patients. In administering radiopharmaceuticals to children, it is important to remember that the biodistribution and kinetics of radiopharmaceuticals are different from adults, particularly in neonates [3, 4]. The administered radioactive dose is distributed over smaller volumes in infants, giving rise to a higher absorbed dose. Consequently, the activity administered must be reduced [3]. It is common practice to express radiopharmaceutical schedules for children as fractions of adult administered amounts [5], and formulae based on the child's age, height, weight and body surface area have been used [5, 6]. In order to establish DRLs, current practices in paediatric nuclear medicine imaging in Ireland have been reviewed.

11 hospitals within Ireland perform nuclear medicine imaging on children. Three of the hospitals are dedicated paediatric hospitals. A questionnaire was sent to the 11 centres requesting information on the types of diagnostic scans performed on children, the standard adult activity per procedure and the method used for calculating the paediatric administered activity. Information was also sought as to the application of a minimum activity and the typical workloads for each procedure type.

All 11 centres completed the survey. Bone scans are the most common procedure type, being performed in 10 of the 11 centres. Renal imaging with 99mTc dimercaptosuccinic acid (DMSA) is the most frequently performed procedure in those centres that perform the investigation. There was variation in adult administered activities for a given examination. For example, for 99mTc mercapto acetyl triglycine (Mag)-3 renograms, the adult administered activity varied from 80 MBq to 185 MBq.

In calculating paediatric administered activity from the standard adult activity, seven centres scale by the child's weight according to Clark's formula. Two centres scale the adult administered activity using factors published by the Paediatric Task Group of the European Association of Nuclear Medicine (EANM) [7]. One dedicated paediatric hospital uses the EANM factors for all examinations except lung perfusion studies, in which case Clark's formula is used, as it places a greater restriction upon the number of particles that may be administered. Only one centre calculated the activity to be administered by scaling the standard adult activity by the age of the child according to (age+1)/(age+7).

For neonates and infants, the use of a fraction of the adult dose would result in too small an administered dose and an entirely unsatisfactory study [3]. Hence, a minimum dose is normally applied [710]. 9 of the 11 centres reported the application of a minimum administered activity. One dedicated paediatric hospital reported two minimum administered activities per examination, depending on the age of the child, with minimum activities for infants and for children aged 16 years.

In this work, the third quartile value of the adult administered activity is recommended as a basis for calculating paediatric DRLs for six procedure types: 99mTc phosphonates for bone scan, 99mTc DMSA renal imaging, 99mTc diethylene triamine pentaacetic acid (DTPA) renogram, 99mTc Mag-3 renogram, 99mTc-pertechnetate thyroid and 99mTc-pertechnetate meckles.

It was found that the majority of centres adopt radiopharmaceutical schedules that utilize weight, based on Clark's formula, in order to scale the adult administered activity for paediatric patients. The adult DRLs were scaled accordingly to yield paediatric DRLs using growth charts [11] to predict typical weights for newborns, 1 year olds, 5 year olds, 10 year olds and 15 year olds. These age groups were considered to be representative of the paediatric age range, and typical weights were obtained by averaging the weights for boys and girls. Paediatric DRLs for the six commonly performed procedures are presented in Table 1Go. In the case of newborn children, it was necessary to apply the minimum dose for 99mTc DMSA renal imaging, 99mTc DTPA renogram, 99mTc Mag-3 renogram and 99mTc-pertechnetate thyroid procedures, as the activity calculated according to weight was less than the recommended minimum activity. The median of the minimum activity was applied in this case.


View this table:
[in this window]
[in a new window]

 
Table 1. Paediatric diagnostic reference levels(MBq) for commonly performed diagnostic procedures

 
Paediatric DRLs have been proposed based upon current practices in Nuclear Medicine Departments within Ireland. These DRLs may serve to aid in the standardization of practice in paediatric nuclear medicine imaging in Ireland.

Yours etc.,

Funding for this research was provided by the Meath Foundation, Adelaide and Meath Hospital Dublin Incorporating the National Children's Hospital, Tallaght, Dublin 24, Ireland.

L GRAY, MSc1, W TORREGGIANI, MD2 and G O'REILLY, PhD1

1 Department of Medical Physics and Bioengineering, St. James's Hospital, James's Street, Dublin 8, Ireland, 2 Department of Radiology, Adelaide and Meath Hospital Dublin Incorporating the National Children's Hospital, Tallaght, Dublin 24, Ireland

References

  1. Council Directive 97/43/EURATOM of 30 June 1997, on health protection of individuals against the dangers of ionising radiation in relation to medical exposure. Official Journal of the European Union L 1997. 180:22–7.
  2. S.I. No. 478, European Communities (Medical Ionising Radiation Protection) Regulations 2002. Available from: http://www.irishstatutebook.ie/2002/en/si/0478.html [Accessed 18 September 2008].
  3. Evans K. Paediatric Radiopharmacy. In: Sampson CB, editor. Textbook of Radiopharmacy, Theory and Practice: Nuclear Medicine. 2nd edition. Amsterdam, the Netherlands: Gordon and Breach Science Publishers, 1994: 327–37.
  4. Sty JR, Starshak RJ. The role of bone scintigraphy in the evaluation of the suspected abused child. Radiology 1983;146:369–75.[Abstract/Free Full Text]
  5. Smith T, Gordon I. An update of radiopharmaceutical schedules in children. Nuc Med Commun 1998;19:1023–36.
  6. Shore RM, Hendee WR. Radiopharmaceutical dosage selection for paediatric nuclear medicine. J Nucl Med 1986;27:287–98.[Abstract/Free Full Text]
  7. The Paediatric Task Group European Association Nuclear Medicine Members: Piepsz A, Hahn K, Roca I, Ciofetta G, Toth G, Gordon I, et al. A radiopharmaceutical schedule for imaging in paediatrics. Eur J Nuc Med 1990;17:127–9.[CrossRef][Medline]
  8. Administration of Radioactive Substances Advisory Committee (ARSAC). Notes for Guidance on the Clinical Administration of Radiopharmaceuticals and Use of Sealed Radioactive Sources. Chilton, UK: ARSAC Support Unit, National Radiological Protection Board (NRPB), 1998.
  9. Rossleigh MA. Renal cortical scintigraphy and diuresis renography in infants and children. J Nucl Med 2001;42:91–5.[Abstract/Free Full Text]
  10. Mandell GA, Eggli DF, Gilday DL, Heyman S, Leonard JC, Miller JH, et al. Society of Nuclear Medicine Procedure Guideline for Renal Cortical Scintigraphy in Children, Version 3.0, June 2003. Available from: http://interactive.snm.org/docs/pg_ch32_0403.pdf [Accessed 18 September 2008].
  11. Hoey HM, Tanner JM, Cox LA. Clinical growth standards for Irish children. Acta Paediatr Scand Suppl 1987;335:1–31.[Medline]




This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GRAY, L
Right arrow Articles by O'REILLY, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GRAY, L
Right arrow Articles by O'REILLY, G


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS